May 23, 2016 by Max Macaluso and Kristine HarjesDrawing Biopharma Concepts With A CrayonPeter Lynch once said, “Never invest in any idea you can’t illustrate with a crayon.” Does that hold true in the highly scientific world of biopharma?
Oct 29, 2015 by Max MacalusoSupernova: What Makes Alnylam a WinnerSee the bigger picture on this innovative biotech -- and find out why it's well-positioned to ride out the industry's volatility.
Oct 13, 2015 by Max MacalusoExploration 22 Research: Alnylam PharmaceuticalsSee the bigger picture on this innovative biotech -- and find out why it's well-positioned to ride out the industry's volatility.
Apr 27, 2015 by Max MacalusoHow Much Bigger Can Celgene Get?With a market cap over $90 billion, does this blue-chip biotech have big-time growth left in it? Let's find out with a detailed look at its past, present, and future.
Apr 13, 2015 by Max MacalusoExploration 16 Research: CelgeneWith a market cap over $90 billion, does this blue-chip biotech have big-time growth left in it? Let's find out with a detailed look at its past, present, and future.
Sep 15, 2014 by Max MacalusoExploration 9 Research: Genomic HealthWith Kimberly Popovits leading the charge, this up-and-coming diagnostics pioneer can emerge as a personalized medicine powerhouse.
Jun 20, 2014 by Max Macaluso and Joel SouthBetter Stock Today Challenge: InvenSense vs. SeadrillIn the spirit of World Cup competition, we’re holding our own tournament in search of the Better Stock Today.
Jun 18, 2014 by Max Macaluso and Joel SouthBetter Stock Today Challenge: InvenSense vs. DistributionNowIn the spirit of World Cup competition, we’re holding our own tournament in search of the Better Stock Today.
Jun 17, 2014 by Max Macaluso and Mark ReethBetter Stock Today Challenge: InvenSense vs. SodaStreamIn the spirit of World Cup competition, we’re holding our own tournament in search of the Better Stock Today.
Jun 17, 2014 by Max Macaluso and David HansonBetter Stock Today Challenge: Apple vs. Annaly CapitalIn the spirit of World Cup competition, we’re holding our own tournament in search of the Better Stock Today.
Jun 15, 2014 by Max Macaluso and Dave WilliamsonBetter Stock Today: InvenSense vs. Johnson & JohnsonIn the spirit of World Cup competition, we’re holding our own tournament in search of the Better Stock Today.
Jun 15, 2014 by Max Macaluso and Joel SouthBetter Stock Today: Vanguard Natural Resources vs. AppleIn the spirit of World Cup competition, we’re holding our own tournament in search of the Better Stock Today.
Jun 9, 2014 by Max Macaluso and Eric BleekerThis Internet of Things Company is Changing Medicine as We Know ItA look at smart-pill pioneer Proteus Digital Health.
Jun 5, 2014 by Max Macaluso and Eric BleekerThe Biggest Threat to Facebook's $19 Billion WhatsApp BuyWill smaller, more intimate communication networks like WhatsApp start pulling people away from sprawling ones like Facebook?
Jun 4, 2014 by Max Macaluso and Eric BleekerWill Your Car Have No Steering Wheel in 5 Years? Google Makes Its Self-Driving-Car MoveWill Google be able to get its driverless car, or at least the tech behind it, into the marketplace? Or will companies not want to play ball with the Internet giant?
Jun 4, 2014 by Max Macaluso and Eric BleekerWhy Is Intel Partnering With a Company You've Probably Never Heard Of?Tech giant Intel has partnered with the relatively unknown Rockchip in an effort to get its chips into inexpensive smartphones and tablets in emerging markets.
Jun 2, 2014 by Max Macaluso and Eric BleekerWill Google's Nest Disrupt the Smart Home Industry?Google Inc.'s Nest thermostat and ADT Corp.'s home security systems are but two of the names filling out the already crowded connected-home market.
May 31, 2014 by Max Macaluso and Eric BleekerWhat's the Future of the Connected TV?A lot of companies are developing new ways to deliver content to your TV, but will the television watching experience really change in the next few years?
May 30, 2014 by Max Macaluso and Eric BleekerAT&T Inc. Dips Its Toes in the Connected HomeAT&T Inc. is trying to connect consumers' homes with its Digital Life program, but will that in any way affect the company's bottom line?
May 28, 2014 by Max MacalusoUnderstanding Multiple Sclerosis: An Interview With Novartis' Dr. Gordon FrancisUnderstanding multiple sclerosis and Novartis' drug Gilenya.
